H-CYTE Inc.  logo

H-CYTE Inc. (HCYT)

Market Open
7 Jul, 19:00
OTCQB OTCQB
$
0. 99
-0.01
-0.5%
$
624.98K Market Cap
- P/E Ratio
- Div Yield
325 Volume
- Eps
$ 1
Previous Close
Add Transaction
Day Range
0.99 1
Year Range
0.5 7
Want to track HCYT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HCYT trading today lower at $0.99, a decrease of -0.5% from yesterday's close, completing a monthly increase of 0% or $0.99. Over the past 12 months, HCYT stock gained 0%.
HCYT is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

HCYT Chart

People also search for

Security Devices International, Inc.
$ 1.02
-1.9231%
Vivos Inc.
$ 0.05
+0.9542%
Telescope Innovations Corp.
$ 0.31
+0.0318%
Inhibitor Therapeutics Inc.
$ 0.08
+9.3333%
Pacific Health Care Organization Inc.
$ 1
0%

H-CYTE Inc. (HCYT) FAQ

What is the stock price today?

The current price is $0.99.

On which exchange is it traded?

H-CYTE Inc. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is HCYT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 624.98K.

Has H-CYTE Inc. ever had a stock split?

No, there has never been a stock split.

H-CYTE Inc. Profile

Biotechnology Industry
Healthcare Sector
Michael W. Yurkowsky CEO
OTCQB Exchange
404124109 CUSIP
US Country
2 Employees
- Last Dividend
- Last Split
- IPO Date
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.

Contact Information

Address: 2202 North West Shore Boulevard
Phone: 888 664 2983